Long term beta-adrenergic blockade reduces tyrosine hydroxylase and dopamine beta-hydroxylase activities in sympathetic ganglia.
D000070:Acebutolol / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism*; D005725:Ganglia, Autonomic / Q000187:drug effects / Q000201:enzymology*; D008790:Metoprolol / Q000494:pharmacology; D009434:Neural Pathways / Q000187:drug effects; D011217:Practolol / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism*
D000319:Adrenergic beta-Antagonists; D000070:Acebutolol; D011433:Propranolol; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D008790:Metoprolol; D011217:Practolol